Table 1.
Minimum inhibitory concentration of fluorescent and conventional antibiotics.
| Fluorescent/Conventional antibiotics | Compound names in the references | MIC (μg/mL) | Species | Ref. |
|---|---|---|---|---|
| Ramoplanin | 5 | Bacillus subtillis | [42] | |
| Fluorescein-Ramoplanin | Ramo-4F1 | 20 | ||
| BODIPY-Ramoplanin | Ramo-4BDP | 10 | ||
| Vancomycin | 0.13 | |||
| Fluorescein-Vancomycin | Van-F1 | 20 | ||
| BODIPY-Vancomycin | Van-BDP | 2.5 | ||
| Polymyxin B | 1 |
Pseudomonas aeruginosa ATCC 27853 |
[43] | |
| Dansyl-polymyxin B | MIPS-9541 | 4 | ||
| Colistin | 1 |
Acinetobacter baumannii ATCC 19606 |
[44] | |
| Dansyl-colistin | FADDI-285 | 4 | ||
| Linezolid | 2 |
Enterococcus faecium Van A ATCC 51559 |
[45] | |
| DMACA-linezolid | Lz-tz-DMACA | 32 | ||
| NBD-linezolid | Lz-tz-NBD | 16 | ||
| Ciprofloxacin | 0.313–0.06 | [46] | ||
| NBD-Ciprofloxacin | Cipro-NBD 3 | 8 | B. subtillis ATCC 6051 | |
| DMACA-Ciprofloxacin | Cipro-DMACA 4 | 4 | ||
| Trimethoprim | 1 |
Staphylococcus aureus ATCC 25923 |
[47] | |
| NBD-Trimethoprim | TMP-3C-TzNBD | 64 | ||
| TMP-4C-TzNBD | 16 | |||
| TMP-5C-TzNBD | 8 | |||
| DMACA-Trimethoprim | TMP-3C-TzDMACA | >64 | ||
| TMP-4C-TzDMACA | >64 | |||
| TMP-5C-TzDMACA | >64 |
DMACA: 7-(dimethylamino)-coumarin-4-acetic acid, NBD: nitrobenzofurazan.